Literature DB >> 837922

Fate of histone messenger RNA in synchronized HeLa cells in the absence of initiation of protein synthesis.

H Stahl, D Gallwitz.   

Abstract

The fate of cytoplasmic histone mRNA was studied under conditions in which initiation of protein synthesis in synchronized HeLa cells is S phase was blocked by increasing the osmolarity of the growth medium with NaCl. In contrast to the interruption of DNA replication with hydroxyurea, which results in an exponential degradation of translatable histone mRNA with a half-life of about 10-13 min, blocking the initiation of protein synthesis leads to only a marginal loss of biologically active histone mRNA in the cytoplasm. When the initiation of protein synthesis was interrupted by treating cells with 150 mM NaCl, 40-50% of the total cytoplasmic histone mRNA previously translated in polyribosomes appears in the cytoplasm integrated into mRNA-protein particle(s) sedimenting between 15 S and 30 S. On the other hand, in untreated S-phase cells or in cells blocked with hydroxyurea only 3-6% of the total translatable histone mRNA is found in the cytoplasm not bound to ribosomes or their subunits. In addition, the degradation of histone mRNA in hydroxyurea-blocked S-phase cells is prevented when the initiation of protein synthesis is inhibited with NaCl. These studies clearly indicate that the inhibition of initiation of protein synthesis per se is not the cause for the rapid degradation of cytoplasmic histone mRNA observed when DNA replication is turned off and that the inactivation of these mRNAs is a process dependent on continuous protein synthesis.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 837922     DOI: 10.1111/j.1432-1033.1977.tb11263.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  18 in total

1.  Changes in the levels of three different classes of histone mRNA during murine erythroleukemia cell differentiation.

Authors:  D T Brown; S E Wellman; D B Sittman
Journal:  Mol Cell Biol       Date:  1985-11       Impact factor: 4.272

2.  Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK.

Authors:  C M Preston
Journal:  J Virol       Date:  1979-01       Impact factor: 5.103

3.  Noncoincidence of histone and DNA synthesis in cleavage cycles of early development.

Authors:  R J Arceci; P R Gross
Journal:  Proc Natl Acad Sci U S A       Date:  1977-11       Impact factor: 11.205

4.  The stem-loop structure at the 3' end of histone mRNA is necessary and sufficient for regulation of histone mRNA stability.

Authors:  N B Pandey; W F Marzluff
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

5.  Histone mRNA degradation in vivo: the first detectable step occurs at or near the 3' terminus.

Authors:  J Ross; S W Peltz; G Kobs; G Brewer
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

6.  Stabilization of tubulin mRNA by inhibition of protein synthesis in sea urchin embryos.

Authors:  Z Y Gong; B P Brandhorst
Journal:  Mol Cell Biol       Date:  1988-08       Impact factor: 4.272

7.  Autogenous regulation of histone mRNA decay by histone proteins in a cell-free system.

Authors:  S W Peltz; J Ross
Journal:  Mol Cell Biol       Date:  1987-12       Impact factor: 4.272

8.  Rapid reversible changes in the rate of histone gene transcription and histone mRNA levels in mouse myeloma cells.

Authors:  R A Graves; W F Marzluff
Journal:  Mol Cell Biol       Date:  1984-02       Impact factor: 4.272

9.  Histone mRNA concentrations are regulated at the level of transcription and mRNA degradation.

Authors:  D B Sittman; R A Graves; W F Marzluff
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

10.  Histone gene switching in murine erythroleukemia cells is differentiation specific and occurs without loss of cell cycle regulation.

Authors:  D T Brown; Y S Yang; D B Sittman
Journal:  Mol Cell Biol       Date:  1988-10       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.